Nemucore Study Published in Molecular Pharmaceutics Furthers Understanding of NMI-350 and Theranostics for Ovarian Cancer
May 23, 2016 08:05 ET
|
Nemucore Medical Innovations, Inc.
WORCESTER, Mass., May 23, 2016 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a clinical-stage biopharmaceutical company dedicated to the development of therapies targeting highly...
Nemucore Medical Innovations Announces Appointment of Nicholas De Monico to its Board of Directors
May 16, 2016 08:05 ET
|
Nemucore Medical Innovations, Inc.
WORCESTER, Mass., May 16, 2016 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies targeting...
Nemucore Medical Innovations Announces NMI-350 ACOG Poster Presentation
May 12, 2016 08:05 ET
|
Nemucore Medical Innovations, Inc.
WORCESTER, Mass., May 12, 2016 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies...
Nemucore Medical Innovations Announces NMI-500 ACOG Poster Presentation
May 11, 2016 08:05 ET
|
Nemucore Medical Innovations, Inc.
WORCESTER, Mass., May 11, 2016 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies...
Nemucore Medical Innovations to Present at Needham & Company’s 15th Annual Healthcare Conference
April 05, 2016 08:05 ET
|
Nemucore Medical Innovations, Inc.
WORCESTER, Mass., April 05, 2016 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies...
Nemucore Medical Innovations Announces Licensing Agreement With Pfenex Inc. Enabling Manufacture of Anti-Cancer Therapeutic NMI-8000, the Biologically Active Form of Mullerian Inhibitory Substance (MIS)
December 14, 2015 08:05 ET
|
Nemucore Medical Innovations, Inc.
WORCESTER, Mass., Dec. 14, 2015 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies...
Nemucore Medical Innovations Announces Appointment of Dr. Michael V. Seiden to Its Board of Directors and Clinical Advisory Board
December 09, 2015 08:05 ET
|
Nemucore Medical Innovations, Inc.
WORCESTER, Mass., Dec. 09, 2015 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies...
Nemucore Medical Innovations Options Clinical-Stage Aurora Kinase Inhibitor GSK1070916 From Cancer Research Technology (CRT)
December 07, 2015 08:10 ET
|
Nemucore Medical Innovations, Inc.
WORCESTER, Mass., Dec. 07, 2015 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies...
Nemucore Medical Innovations Completes Series A Financing
December 07, 2015 08:05 ET
|
Nemucore Medical Innovations, Inc.
WORCESTER, Mass., Dec. 07, 2015 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies...